Mikami Koji 三上浩司

Researcher Number	70567205
Affiliation (Current)	2026: 兵庫医科大学, 医学部, 講師
Affiliation (based on the past Project Information) *help	2019 – 2020: 兵庫医科大学, 医学部, 講師
Review Section/Research Field	Principal Investigator Basic Section 53030:Respiratory medicine-related
Keywords	Principal Investigator スーパーアパタイト / 核酸 / KRAS / KRAS変異 / microRNA / 核酸治療 / 肺癌 / KRAS遺伝子変異

Developing the novel therapeutic strategy with the oligonucleotide therapy against KRAS mutation-positive lung cancerPrincipal Investigator
- Principal Investigator
  
  Mikami Koji
- Project Period (FY)
  2019 – 2020
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 53030:Respiratory medicine-related
- Research Institution
  Hyogo Medical University

All 2020 2019

All Journal Article Presentation

[Journal Article] Tumor‐associated macrophage‐derived inflammatory cytokine enhances malignant potential of malignant pleural mesothelioma2020
- Author(s)
  Horio Daisuke、Minami Toshiyuki、Kitai Hidemi、Ishigaki Hirotoshi、Higashiguchi Yoko、Kondo Nobuyuki、Hirota Seiichi、Kitajima Kazuhiro、Nakajima Yasuhiro、Koda Yuichi、Fujimoto Eriko、Negi Yoshiki、Niki Maiko、Kanemura Shingo、Shibata Eisuke、Mikami Koji、Takahashi Ryo、Yokoi Takashi、Kuribayashi Kozo、Kijima Takashi
- Journal Title
  
  Cancer Science
  
  Volume: - Issue: 8 Pages: 2895-2906
- DOI
  10.1111/cas.14523
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K15962, KAKENHI-PROJECT-19K17653, KAKENHI-PROJECT-19K17654
[Journal Article] EphA2 inhibition suppresses proliferation of small-cell lung cancer cells through inducing cell cycle arrest2019
- Author(s)
  Ishigaki Hirotoshi、Minami Toshiyuki、Morimura Osamu、Kitai Hidemi、Horio Daisuke、Koda Yuichi、Fujimoto Eriko、Negi Yoshiki、Nakajima Yasuhiro、Niki Maiko、Kanemura Shingo、Shibata Eisuke、Mikami Koji、Takahashi Ryo、Yokoi Takashi、Kuribayashi Kozo、Kijima Takashi
- Journal Title
  
  Biochemical and Biophysical Research Communications
  
  Volume: 519 Issue: 4 Pages: 846-853
- DOI
  10.1016/j.bbrc.2019.09.076
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K17653, KAKENHI-PROJECT-18K15962, KAKENHI-PROJECT-18K15963
[Journal Article] Analysis of Pleiotropic Effects of Nivolumab in Pretreated Advanced or Recurrent Non-small Cell Lung Cancer Cases2019
- Author(s)
  AKANO YUMIKO、KURIBAYASHI KOZO、FUNAGUCHI NORIHIKO、KODA YUICHI、FUJIMOTO ERIKO、MIKAMI KOJI、MINAMI TOSHIYUKI、TAKAHASHI RYO、YOKOI TAKASHI、KIJIMA TAKASHI
- Journal Title
  
  In Vivo
  
  Volume: 33 Issue: 2 Pages: 507-514
- DOI
  10.21873/invivo.11503
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K17653
[Presentation] Efficacy and safety of nivolumab for malignant mesothelioma in the real world.2020
- Author(s)
  Koji Mikami, Takashi Yokoi, Ryo Takahashi, Eisuke Shibata, Maiko Niki, Yasuhiro Nakajima, Yoshiki Negi, Hirotoshi Ishigaki, Akio Tada, Tomoki Higashiyama, Takao Kamei, Toshiyuki Minami, Kozo Kuribayashi, Takashi Kijima
- Organizer
  American Society of Clinical Oncology
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K17653
[Presentation] Neutrophil-to- lymphocyte ratio as a predictive factor for hyperprogressive disease in NSCLC patients treated with immune checkpoint inhibitor2019
- Author(s)
  R.Takahashi, E.Shibata, T.Higashiyama, T.kamei, A.Tada, H.Ishigaki, Y.Nakajima, Y.Negi, M.Niki, K.Mikami, T.Minami, T.Yokoi, K.Kuribayashi, T.Kijima
- Organizer
  ESMO Asia Congress 2019
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K17653
[Presentation] 当院における手術不能局所進行非小細胞肺癌に対するDurvalumab投与経験2019
- Author(s)
  柴田英輔横井崇三上浩司大搗泰一郎中島康博二木麻衣子幸田裕一袮木芳樹赤野友美子石垣裕敏多田陽郎東山友樹亀井貴雄南俊行高橋良栗林康造木島貴志
- Organizer
  第17回日本臨床腫瘍学会学術集会
- Data Source
  KAKENHI-PROJECT-19K17653
[Presentation] 悪性胸膜中皮腫微小環境中の腫瘍関連マクロファージにおけるインフラマソームの役割2019
- Author(s)
  堀尾大介南俊行北井秀美中島康博幸田裕一藤本英利子袮木芳樹金村晋吾柴田英輔三上浩司高橋良横井崇栗林康造木島貴志
- Organizer
  第59回日本呼吸器学会学術講演会
- Data Source
  KAKENHI-PROJECT-19K17653
[Presentation] 抗PD-1抗体治療歴を有する進行非小細胞肺癌に対する抗PD-L1抗体の検討2019
- Author(s)
  二木麻衣子横井崇三上浩司大搗泰一郎柴田英輔中島康博幸田裕一袮木芳樹赤野友美子石垣裕敏多田陽郎東山友樹亀井貴雄南俊行高橋良栗林康造木島貴志
- Organizer
  第17回日本臨床腫瘍学会学術集会
- Data Source
  KAKENHI-PROJECT-19K17653
[Presentation] 胸水合併T790M変異陽性肺癌へのオシメルチニブの有効性の検討2019
- Author(s)
  三上浩司横井崇大搗泰一郎柴田英輔中島康博二木麻衣子幸田裕一袮木芳樹赤野友美子石垣裕敏多田陽郎東山友樹亀井貴雄南俊行高橋良栗林康造木島貴志
- Organizer
  第17回日本臨床腫瘍学会学術集会
- Data Source
  KAKENHI-PROJECT-19K17653

1. 南俊行

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Mikami Koji 三上 浩司

Research Projects

Research Products

Co-Researchers

Developing the novel therapeutic strategy with the oligonucleotide therapy against KRAS mutation-positive lung cancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] Tumor‐associated macrophage‐derived inflammatory cytokine enhances malignant potential of malignant pleural mesothelioma2020

Author(s)

Journal Title

DOI

Data Source

[Journal Article] EphA2 inhibition suppresses proliferation of small-cell lung cancer cells through inducing cell cycle arrest2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Analysis of Pleiotropic Effects of Nivolumab in Pretreated Advanced or Recurrent Non-small Cell Lung Cancer Cases2019

Author(s)

Journal Title

DOI

Data Source

[Presentation] Efficacy and safety of nivolumab for malignant mesothelioma in the real world.2020

Author(s)

Organizer

Data Source

[Presentation] Neutrophil-to- lymphocyte ratio as a predictive factor for hyperprogressive disease in NSCLC patients treated with immune checkpoint inhibitor2019

Author(s)

Organizer

Data Source

[Presentation] 当院における手術不能局所進行非小細胞肺癌に対するDurvalumab投与経験2019

Author(s)

Organizer

Data Source

[Presentation] 悪性胸膜中皮腫微小環境中の腫瘍関連マクロファージにおけるインフラマソームの役割2019

Author(s)

Organizer

Data Source

[Presentation] 抗PD-1抗体治療歴を有する進行非小細胞肺癌に対する抗PD-L1抗体の検討2019

Author(s)

Organizer

Data Source

[Presentation] 胸水合併T790M変異陽性肺癌へのオシメルチニブの有効性の検討2019

Author(s)

Organizer

Data Source

Mikami Koji 三上浩司